Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
A. Albors-Vaquer, A. Rizvi, M. Matzapetakis, P. Lamosa, A. V. Coelho, A. B. Patel, S. C. Mande, S. Gaddam, A. Pineda-Lucena, S. Banerjee & L. Puchades-Carrasco. (2020) Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers. Emerging Microbes & Infections 9:1, pages 1131-1139.
Read now
Read now
Justin T Denholm, Emma S McBryde, Damon P Eisen, Jocelyn S Penington, Caroline Chen & Alan C Street. (2014) Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study. Drug, Healthcare and Patient Safety 6, pages 145-149.
Read now
Read now
Articles from other publishers (19)
Ashlan J. Kunz Coyne, Anthony M. Casapao & Eric F. Egelund. 2023. Tuberculosis. Tuberculosis
257
275
.
Dženan Kovačić, Adna Softić, Adna Salihović & Jovana Jotanović. 2022. Macrophages - Celebrating 140 Years of Discovery. Macrophages - Celebrating 140 Years of Discovery.
Mohsen Heidary, Maryam Shirani, Melika Moradi, Mehdi Goudarzi, Ramin Pouriran, Tayebe Rezaeian & Saeed Khoshnood. (2022) Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment. European Journal of Microbiology and Immunology 12:1, pages 1-17.
Crossref
Crossref
Eugene B. Postnikov, Elena A. Lebedeva, Andrey Yu. Zyubin & Anastasia I. Lavrova. (2021) The Cascade Hilbert-Zero Decomposition: A Novel Method for Peaks Resolution and Its Application to Raman Spectra. Mathematics 9:21, pages 2802.
Crossref
Crossref
Gokul Raj Kathamuthu, Kadar Moideen, Rathinam Sridhar, Dhanaraj Baskaran & Subash Babu. (2021) Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis. PLOS ONE 16:6, pages e0253534.
Crossref
Crossref
Sanzhar Zhetkenev, Ayauly Khassan, Armanay Khamzina, Alpamys Issanov, Byron Crape, Ainur Akilzhanova, Dauren Yerezhepov, Ulan Kozhamkulov & Chee Kai Chan. (2021) Association of rs12722 COL5A1 with pulmonary tuberculosis: a preliminary case-control study in a Kazakhstani population. Molecular Biology Reports 48:1, pages 691-699.
Crossref
Crossref
Jonathan Mayito, Irene Andia Biraro, Stephen T. Reece, Adrian R. Martineau & David P. Kateete. (2020) Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of Ugandan adults with latent infection: a cross-sectional and nested prospective study. AAS Open Research 3, pages 34.
Crossref
Crossref
Samantha Leong, Yue Zhao, Rodrigo Ribeiro-Rodrigues, Edward C. Jones-López, Carlos Acuña-Villaorduña, Patricia Marques Rodrigues, Moises Palaci, David Alland, Reynaldo Dietze, Jerrold J. Ellner, W. Evan Johnson & Padmini Salgame. (2020) Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB. Tuberculosis 120, pages 101898.
Crossref
Crossref
Muhammad F. Rasool, Sundus Khalid, Abdul Majeed, Hamid Saeed, Imran Imran, Mohamed Mohany, Salim S. Al-Rejaie & Faleh Alqahtani. (2019) Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations. Pharmaceutics 11:11, pages 578.
Crossref
Crossref
Cihad Dundar, Derya Oztomurcuk & Ozlem Terzi. (2019) Regional success on screening and chemoprophylaxis in contacts of patients with pulmonary tuberculosis in Turkey: a dispensary experience in 2016–2017. Transactions of The Royal Society of Tropical Medicine and Hygiene 113:6, pages 351-355.
Crossref
Crossref
Dinesh Babu, Andrew G. Morgan, Béla Reiz, Randy M. Whittal, Sarah Almas, Paige Lacy & Arno G. Siraki. (2019) Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD+. Chemico-Biological Interactions 305, pages 48-53.
Crossref
Crossref
Binit Vaidya & Shweta Nakarmi. (2019) Simultaneous Adalimumab and Antitubercular Treatment for Latent Tubercular Infection: An Experience from Nepal. International Journal of Rheumatology 2019, pages 1-6.
Crossref
Crossref
Shachi Pranjal Vyas & Ritobrata Goswami. (2017) Striking the right immunological balance prevents progression of tuberculosis. Inflammation Research 66:12, pages 1031-1056.
Crossref
Crossref
Ram Prasad Bhusal, Ghader Bashiri, Brooke X.C. Kwai, Jonathan Sperry & Ivanhoe K.H. Leung. (2017) Targeting isocitrate lyase for the treatment of latent tuberculosis. Drug Discovery Today 22:7, pages 1008-1016.
Crossref
Crossref
Andreas Sandgren, Marije Vonk Noordegraaf-Schouten, Femke van Kessel, Anke Stuurman, Anouk Oordt-Speets & Marieke J. van der Werf. (2016) Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infectious Diseases 16:1.
Crossref
Crossref
James M. Trauer, Nompilo Moyo, Ee-Laine Tay, Katie Dale, Romain Ragonnet, Emma S. McBryde & Justin T. Denholm. (2016) Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?. Chest 149:2, pages 516-525.
Crossref
Crossref
Vijay Soni, Sandeep Upadhayay, Priyanka Suryadevara, Ganesh Samla, Archana Singh, Perumal Yogeeswari, Dharmarajan Sriram & Vinay Kumar Nandicoori. (2015) Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen. PLOS Pathogens 11:10, pages e1005235.
Crossref
Crossref
Beena & Diwan S. Rawat. (2013) Antituberculosis Drug Research: A Critical Overview. Medicinal Research Reviews 33:4, pages 693-764.
Crossref
Crossref
Emma S McBrydeJustin T Denholm. (2012) Risk of active tuberculosis in immigrants: effects of age, region of origin and time since arrival in a low‐exposure setting. Medical Journal of Australia 197:8, pages 458-461.
Crossref
Crossref